CN Bio logoCN Bio logoCN Bio logoCN Bio logo
  • Products
    • Explore our solutions


      PhysioMimix™ products enable you to recreate complex human biology and accurately predict human drug responses

      PhysioMimix OOC

      PhysioMimix OOC systems
      Learn more

      Consumables

      • Multi-chip plates
      • 3D validated cells
      • NASH-in-a-box
      Learn more

      Models

      • Single-organ models
      • Multi-organ models

      Support packages

      • PhysioMimix™ support packages
  • Applications
    • Discover the applications


      Investigate the application areas that our PhysioMimix™ products and services support

      Learn more

      Disease modeling

      • Non-Alcoholic Steatohepatitis
      • Hepatitis B
      • Oncology
      • COVID-19
      Learn more

      Safety toxicology

      • Drug-induced liver injury
      • Immune-mediated toxicities
      Learn more

      ADME

      • Drug absorption
      • Drug metabolism
      • Drug bioavailability
      Learn more
  • Services
    • Studies as a service


      Our team will work collaboratively with you to design a study around your research goals and generate actionable data within weeks

      Learn more
      NAFLD / NASH icons

      NAFLD / NASH

      Drug-induced liver injury icon

      Drug-induced liver injury

      icon adme |

      ADME

      Oncology icon

      Oncology

  • Resources
  • Company
    • About us


      Meet the team, explore our culture and discover what to expect when working with us

      CN Bio team photo
      About us

      Latest news

      • The FDA further expands collaboration with CN Bio to evaluate the PhysioMimix Multi-organ microphysiological system

      • The U.S. FDA Modernization Act 2.0. Now the animal testing mandate is removed, learn what can be embraced in its place.

      • CN Bio appoints Dr Paul Brooks as Chief Executive Officer

      View all news

      Upcoming Events

      • SLAS2023

      • SOT 2023

      • WORD 2023

      • SLAS Europe 2023

      • MPS World Summit 2023

      View all events

      Join the team!

      View all jobs
  • Contact
  • Products
    • PhysioMimix™ OOC Microphysiological Systems
    • Consumables
      • PhysioMimix™ multi-chip plates
      • 3D validated cells
      • NASH-in-a-box
    • Organ-on-a-chip models
    • Support packages
  • Applications
    • Disease modeling
    • Safety toxicology
    • ADME
  • Services
    • Non-Alcoholic Steatohepatitis
    • Drug-Induced Liver Injury
    • ADME
  • Resources
  • Company
    • About us
    • Events
    • News
    • Careers
  • Contact
  • Skip to main content
  • Skip to footer
Chat live with an expert

PhysioMimix™ multi-chip plates

Our range of Multi-chip plates


MPS-LC12 Liver plate

MPS-LC12

 Liver plate

Designed to create optimal conditions for primary human hepatocytes and non-parenchymal cells (NPCs)

Learn more
MPS-T12 Barrier plate

MPS-T12

Barrier plate

Designed to achieve more physiologically relevant biological barrier models, such as gut and lung

Learn more
MPS-TL6 Dual-organ plate

MPS-TL6

Dual-organ plate

Designed to enable two-organ communication between interconnected barrier and liver models

Learn more

Advancing human-relevant research


Advance the pace and human relevance of your research with our approachable, customizable and cost-effective range of Multi-chip plates.

Our PhysioMimix range of Multi-chip plates is purpose-designed to more accurately recapitulate the physiology and function of human organs and tissues in vitro.

Our plates offer ultimate flexibility. You can adapt our models to suit your research needs, or bring your in-house models into a PhysioMimix format to increase your throughput capabilities.

Our solution is designed around a familiar plate-based format that contains multiple chips to enable rapid adoption, while increasing throughput and decreasing cost.

LC12 plate in PhysioMimix driver

Plate features

PhysioMimix Multi-chip plates provide the following features:

LC12 plate and tube
  • PDMS-free plates reduce non-specific binding for result accuracy
  • Multi-chip design increases throughput capacity and reduces cost
  • Fluidically isolated chips allow multiple conditions to be explored within a plate
  • Purpose-designed plates support the needs of single-and multi-organ models
  • Adjustable flow improves physiological relevance
  • Inter- and intra-organ flow permits the inclusion of circulating immune cells
  • Longitudinal repeat sampling capability enables time course studies
  • Large sampling volumes facilitate highly multiplexed end-point analysis
  • Open-well format for easy adoption and model customization

Related consumables


3D validated cells

Choose cells from our 3D validated cell supply catalog and accelerate your route to generating reliable and robust human translatable data from organ-on-a-chip research.

Learn more

NASH-in-a-box

NASH-in-a-box contains everything required to recreate our industry-validated human in vitro Non-Alcoholic Steatohepatitis (NASH) model in your own laboratory.

Learn more

Speak to our experts

Speak directly with one of our OOC experts to see how our products and services can support your studies

Request a meeting

Footer

CN Bio logo

332 Cambridge Science Park, Milton Road
Cambridge, CB4 0WN

+44 (0) 1223 737941

Privacy | Cookies | Terms | Regulatory | Accessibility

©2023 CN Bio Innovations Ltd
Registered No. ‍06517359. VAT No. 978184563

Latest news

  • The FDA further expands collaboration with CN Bio to evaluate the PhysioMimix Multi-organ microphysiological system January 17, 2023
  • The U.S. FDA Modernization Act 2.0. Now the animal testing mandate is removed, learn what can be embraced in its place. January 9, 2023
  • CN Bio appoints Dr Paul Brooks as Chief Executive Officer December 19, 2022

Upcoming events

MPS World Summit 2023 June 26-30, 2023

SLAS Europe 2023 May 22-26, 2023

SLAS2023 February 25 - March 1, 2023